Ilina Singh is Professor of Neuroscience & Society at the University of Oxford, where she holds a joint appointment between the Department of Psychiatry and the Faculty of Philosophy (Oxford Centre for Neuroethics and Uehiro Centre). Her work examines the psychosocial and ethical implications of advances in biomedicine and neuroscience for young people and families and reflects a longstanding commitment to bringing the first person experiences of children and young people into ethicalevaluation, clinical decision-making and policy-making.

Recent projects include the ADHD VOICES project (www.adhdvoices.com) Neuroenhancement Responsible Research and Innovation (www.nerri.eu); and the Urban Brain Project (www.urbanbrainlab.com). In 2014, Professor Singh received a Wellcome Trust Senior Investigator Award for a study entitled: Becoming Good: Early Intervention and Moral Development in Child Psychiatry.

Ilina has contributed to various scientific and policy groups, including the UK National Institutes of Clinical Excellence (NICE), US National Institutes of Mental Health (NIMH) and the Nuffield Council on Bioethics. She is a co-chair of the Ethics Advisory Board for the EU-AIMS project on autism treatments (www.eu-aims.eu) and an expert advisor for the National Autism Project (www.nationalautismproject.org.uk).

Ilina has published widely in eminent journals, including Nature, Nature Reviews Neuroscience, Social Science and Medicine, and the American Journal of Bioethics. She is the lead editor of a new volume: BioPrediction, Biomarkers and Bad Behavior: Scientific, Ethical and Legal Challenges, published by Oxford University Press. She has acted as an advisor to the Nuffield Council on Bioethics, NICE, NIMH and other organisations. She is co-editor of the journal BioSocieties and on the editorial board of the American Journal of Bioethics-Neuroscience and Qualitative Psychology.

View Ilina’s University of Oxford profile

Publications

• Childhood: a suitable case for treatment?
  Singh I. and Wessely S., (2015), The Lancet Psychiatry, 2, 661 – 666
• Can Guidelines Help Reduce the Medicalization of Early Childhood?
  Graf WD. and Singh I., (2015), The Journal of Pediatrics, 166, 1344 – 1346
• Autism research beyond the bench
  Singh I. and Elsabbagh M., (2014), Autism, 18, 754 – 755
• Attention deficit hyperactivity disorder: improving performance through brain–computer interface
  Bárd I. and Singh I., (2014), Handbook of Neuroethics, 741 – 762
• Contest and Diagnosis
  Trundle C. et al, (2014), Sociology of Diagnosis
• Urban life and mental health: Re-visiting politics, society and biology
  Fizgerald D. et al, (2014), Discover Society
• Authenticity, Values, and Context in Mental Disorder: The Case of Children with ADHD
  Singh I., (2014), Philosophy, Psychology & Psychiatry, 21, 237 – 240
• Robust resilience and substantial interest: a survey of pharmacological cognitive enhancement among university students in the UK and Ireland.
  Singh I. et al, (2014), PLoS One, 9
• Globalization and cognitive enhancement: emerging social and ethical challenges for ADHD clinicians.
  Singh I. et al, (2013), Curr Psychiatry Rep, 15
• Brain talk: power and negotiation in children’s discourse about self, brain and behaviour.
  Singh I., (2013), Sociol Health Illn, 35, 813 – 827
• Not robots: children’s perspectives on authenticity, moral agency and stimulant drug treatments.
  Singh I., (2013), J Med Ethics, 39, 359 – 366
• Victimology versus character: new perspectives on the use of stimulant drugs in children
  Singh I., (2013), Journal of Medical Ethics, 39, 372 – 373
• ADHD and stigma: the role of environmental factors
  Singh I. and Baker L., (2013), ADHD in Practice, 5, 4 – 7
• Brain enhancement in children
  Singh I. and Kelleher KJ., (2013), Neuroethics in Practice, 16 – 34
• What should we do about student use of cognitive enhancers? An analysis of current evidence
  Ragan CI. et al, (2013), Neuropharmacology, 64, 588 – 595
• Human development, nature and nurture: Working beyond the divide
  Singh I., (2012), BioSocieties, 7, 308 – 321
• Authenticity and mental health: Letter on Hope et al
  Singh I., (2012), Hastings Center Report
• UK survey on student use of cognitive enhancers
  Singh I. and Bard I., (2012), Nature Correspondence
• VOICES: Voices on Identity, Childhood, Ethics & Stimulants: Children join the debate
  Singh I., (2012)
• A response to Pellicano et al.
  Walsh P. et al, (2011), Nature Reviews Neuroscience, 12
• In search of biomarkers for autism: scientific, social and ethical challenges.
  Walsh P. et al, (2011), Nat Rev Neurosci, 12, 603 – 612
• A disorder of anger and aggression: children’s perspectives on attention deficit/hyperactivity disorder in the UK.
  Singh I., (2011), Soc Sci Med, 73, 889 – 896
• Neuroscience and eating disorders: Implications of a neurobiological model for patients and families
  Singh I. and Wengaard A., (2011), Eating Disorders: Neuroscientific Advances and Clinical Applications
• Listening to children with ADHD
  Singh I., (2011)
• Young People’s Experience of ADHD and Stimulant Medication: A Qualitative Study for the NICE Guideline
  Singh I. et al, (2010), Child and Adolescent Mental Health, 15, 186 – 192
• ELSI Neuroscience Should Have a Broad Scope
  Singh I., (2010), AJOB Neuroscience, 1, 11 – 12
• The challenges and opportunities of qualitative health research with children
  Singh I. and Keenan S., (2010), The SAGE Handbook of Qualitative Methods in Health Research
• Neuroenhancement in Young People: Proposal for Research, Policy, and Clinical Management
  Singh I. and Kelleher KJ., (2010), AJOB Neuroscience, 1, 3 – 16
• Being and thinking
  Singh I. et al, (2010), Surviving Healthcare, 222 – 245
• Cryptic Coercion
  Ilina Singh None., (2010), Hastings Center Report, 40, 22 – 23
• Biomarkers in psychiatry.
  Singh I. and Rose N., (2009), Nature, 460, 202 – 207
• What We Should Really Worry About in Pediatric Functional Magnetic Resonance Imaging (fMRI)
  Connors CM. and Singh I., (2009), The American Journal of Bioethics, 9, 16 – 18
• Psychotropic drugs in childhood: The case of stimulants
  Singh I., (2009), Pediatric Bioethics
• Beyond polemics: science and ethics of ADHD.
  Singh I., (2008), Nat Rev Neurosci, 9, 957 – 964
• Capacity, consent and electroconvulsive therapy: A qualitative and cross-sectional study
  Hotopf M. et al, (2008), Journal of Mental Health, 17, 315 – 325
• ADHD, culture and education
  Singh I., (2008), Early Child Development and Care, 178, 347 – 361
• Service users’ experiences of stimulant drug medication
  Singh I. et al, (2008), 94 – 98
• Psychiatrists’ views on ECT in the draft Mental Health Bill: Focus group and interview study
  Hotopf M. et al, (2008), Journal of Public Mental Health, 17, 315 – 325
• ‘I Bambini e le Droghe’: The Right to Ritalin vs the Right to Childhood in Italy
  Frazzetto G. et al, (2007), BioSocieties, 2, 393 – 412
• Capacity and competence in children as research participants. Researchers have been reluctant to include children in health research on the basis of potentially naive assumptions.
  Singh I., (2007), EMBO Rep, 8 Spec No, S35 – S39
• Clinical implications of ethical concepts: moral self-understandings in children taking methylphenidate for ADHD.
  Singh I., (2007), Clin Child Psychol Psychiatry, 12, 167 – 182
• Authentic Problematics of Empirical Ethics: Response to D. Micah Hester
  Singh I., (2007), Clinical Child Psychology and Psychiatry, 12, 189 – 190
• Not just naughty: 50 years of stimulant drug advertising
  Singh I., (2007), Medicating Modern America, 131 – 155
• A Framework for Understanding Trends in ADHD Diagnoses and Stimulant Drug Treatment: Schools and Schooling as a Case Study
  Singh I., (2006), BioSocieties, 1, 439 – 452
• The pharmacogenomics of depression: mapping the social and ethical impact
  Barr M. et al, (2005), Journal of Public Mental Health, 4, 33 – 41
• Will the “Real Boy” Please Behave: Dosing Dilemmas for Parents of Boys with ADHD
  Singh I., (2005), The American Journal of Bioethics, 5, 34 – 47
• Response to Commentators on “Will the ‘Real Boy’ Please Behave: Dosing Dilemmas for Parents of Boys with ADHD”
  Singh I., (2005), The American Journal of Bioethics, 5, W10 – W12
• Doing their jobs: mothering with Ritalin in a culture of mother-blame.
  Singh I., (2004), Soc Sci Med, 59, 1193 – 1205
• Boys will be boys: fathers’ perspectives on ADHD symptoms, diagnosis, and drug treatment.
  Singh I., (2003), Harv Rev Psychiatry, 11, 308 – 316
• Bad boys, good mothers, and the “miracle” of Ritalin
  Singh I., (2002), SCIENCE IN CONTEXT, 15, 577 – 603
• Biology in context: Social and cultural perspectives on ADHD
  Singh I., Children and Society: the international journal of childhood and children’s services, 16, 360 – 367